Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-02

Clinical Trial Update: Prucalopride for Cognitive Functioning in Schizophrenia [NA]

View source ↗

Summary

A ClinicalTrials.gov entry describes a study investigating prucalopride for improving cognitive functioning in individuals with schizophrenia. The trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRUCALOPRIDE (Prucalopride)

Snippet

Sponsor: University of Pittsburgh | Conditions: Schizophrenia | NA | Status: NOT_YET_RECRUITING